Quote | Super Quote
Fund Raising
Date   Code Name No. of Shares Issued Issue Price Total Fund Raised Type % of issued shs Raising Method
(Reason)
17/04/2024 03330LINGBAO GOLD26.917MHKD 3.020HKD 81.300MH2.213Placing/Issue
(Business Development)
17/04/2024 01532CHINA PARTYTIME295.544MHKD 0.080HKD 23.600MShares20.000Placing/Issue
(Enlarging the capital base;Business Development;Debt Repayment)
17/04/2024 01850HSC RESOURCES28.800MHKD 0.630HKD 18.144MShares20.000Placing/Issue
(Enlarging the capital base;Business Development;Debt Repayment)
17/04/2024 08229FUTURE DATA7.143MHKD 0.420HKD 3.000MShares1.307Consideration Issue
(Acquisition Acquisition of business in asset management in Hong Kong)
16/04/2024 06683STARPLUS LEGEND31.522MHKD 7.100HKD 223.800MShares3.931Placing/Issue
(Enlarging the capital base;Business Development)
16/04/2024 08471REACH NEW HLDGS70.000MHKD 0.070HKD 4.900MShares7.368Placing/Issue
(Enlarging the capital base;Business Development)
15/04/2024 01143CN ENGY STORAGE11.260MHKD 1.590HKD 17.900MShares5.752Placing/Issue
(Enlarging the capital base;Business Development)
14/04/2024 01818ZHAOJIN MINING132.000MHKD 13.200HKD 1.742BH4.036Placing/Issue
(Enlarging the capital base;Debt Repayment)
13/04/2024 01792CMON361.200MHKD 0.030HKD 10.800MShares20.000Placing/Issue
(Enlarging the capital base)
12/04/2024 08245SHANYU GROUP172.350MHKD 0.034HKD 5.860MShares20.000Placing/Issue
(Enlarging the capital base)
12/04/2024 01270LANGHAM-SS55.433MHKD 0.646HKD 35.810MShares1.670Consideration Issue
(Fee Payment)
11/04/2024 01025KNT HOLDINGS168.480MHKD 0.209HKD 35.212MShares19.999Top Up Placing
(Enlarging the capital base)
10/04/2024 01413KWONG LUEN ENG200.000MHKD 0.180HKD 36.000MShares20.000Placing/Issue
(Enlarging the capital base)
09/04/2024 01258CHINFMINING163.000MHKD 6.000HKD 978.000MShares4.359Top Up Placing
(Enlarging the capital base;Business Development)
09/04/2024 03860EPS HEALTH TECH22.177MHKD 0.992HKD 22.000MShares4.435Placing/Issue
(Enlarging the capital base)
09/04/2024 02191SF REIT6.238MHKD 2.364HKD 14.747MShares0.775Consideration Issue
(Fee Payment)
09/04/2024 02400XD INC9.600MHKD 14.200HKD 136.320MShares1.998Consideration Issue
(Acquisition Further acquisition of business in publishing & operating games overseas; Consideration equal to USD 17.34 mil)
09/04/2024 08401STREAM IDEAS40.000MHKD 0.127HKD 5.060MShares20.000Placing/Issue
(Enlarging the capital base;Debt Repayment)
09/04/2024 00905WALNUT CAP350.167MHKD 0.162HKD 57.000MShares50.000Rights Issue/Open Offer
(Enlarging the capital base;Business Development Rts 1 for 2 (on non-underwritten basis))
08/04/2024 01007LONGHUI INTL63.224MHKD 0.480HKD 30.300MShares60.000Placing/Issue
(Enlarging the capital base;Debt Repayment Net proceeds equal to RMB 25.9 mil)
08/04/2024 00197HENG TAI52.535MHKD 0.350HKD 18.400MShares50.000Rights Issue/Open Offer
(Enlarging the capital base;Business Development Rts 1 for 2 (on non-underwritten basis))
08/04/2024 02330CHINA UPTOWN610.714MHKD 0.150HKD 91.600MShares200.000Rights Issue/Open Offer
(Enlarging the capital base;Business Development;Debt Repayment Rts 2 for 1 (on non-underwritten basis))
08/04/2024 08446BRIGHTSTAR TECH101.488MHKD 0.165HKD 16.746MShares12.480Placing/Issue
(Enlarging the capital base)
05/04/2024 00853MICROPORT----USD 150.000MConvertible Bonds0.000Placing/Issue
(Enlarging the capital base;Debt Repayment)
03/04/2024 01718WAN KEI GROUP19.200MHKD 1.000HKD 19.200MShares20.000Placing/Issue
(Enlarging the capital base)
02/04/2024 08622HUAKANG BIOMED31.000MHKD 0.097HKD 3.007MShares6.603Placing/Issue
(Enlarging the capital base)
02/04/2024 01572CHINA ART FIN12.500MHKD 0.120HKD 1.500MShares0.745Placing/Issue
(Business Development)
01/04/2024 09995REMEGEN70.763M--RMB 2.550BA13.000Placing/Issue
(Business Development)
28/03/2024 00399INNOVATIVE PHAR114.000MHKD 0.175HKD 19.950MShares6.616Placing/Issue
(Enlarging the capital base)
27/03/2024 01468KINGKEY FIN INT1.526BHKD 0.060HKD 91.600MShares20.000Placing/Issue
(Debt Repayment)
26/03/2024 06128GRAPHEX GROUP2.400MHKD 0.179HKD 429,600Shares0.267Consideration Issue
(Business Development Pay for consultation fees; Proceeds equal to USD 55077)
25/03/2024 08645BYTE META120.000MHKD 0.218HKD 26.200MShares20.000Placing/Issue
(Enlarging the capital base;Business Development)
25/03/2024 08037CH BIOTECH SER----HKD 88.000MConvertible Bonds0.000Placing/Issue
(Enlarging the capital base;Business Development)
25/03/2024 01426SPRING REIT5.228MHKD 2.000HKD 10.456MShares0.363Consideration Issue
(Fee Payment)
25/03/2024 08540VICTORY SEC4.800MHKD 2.300HKD 11.040MShares2.394Placing/Issue
(Enlarging the capital base;Business Development)
25/03/2024 08340ZIJING INTL FIN448.000MHKD 0.120HKD 53.800MShares500.000Rights Issue/Open Offer
(Enlarging the capital base;Business Development;Debt Repayment Rts 5 for 1 (on non-underwritten basis))
25/03/2024 08540VICTORY SEC2.400MHKD 2.800HKD 6.720MShares1.197Placing/Issue
(Enlarging the capital base;Business Development)
24/03/2024 00405YUEXIU REIT80.000MHKD 1.050HKD 84.000MShares1.627Consideration Issue
(Fee Payment Consideration equal to RMB 76.21 mil)
22/03/2024 03893CROSSTEC25.920MHKD 0.260HKD 6.740MShares20.000Placing/Issue
(Business Development)
22/03/2024 08299GRAND T G GOLD310.638MHKD 0.141HKD 43.800MShares5.188Placing/Issue
(Enlarging the capital base;Business Development)
 
 1    2    3    4    5    6    7    8    9    10  
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.